A detailed history of Principal Street Partners, LLC transactions in Novartis Ag stock. As of the latest transaction made, Principal Street Partners, LLC holds 6,080 shares of NVS stock, worth $647,155. This represents 0.11% of its overall portfolio holdings.

Number of Shares
6,080
Previous 1,989 205.68%
Holding current value
$647,155
Previous $200,000 194.0%
% of portfolio
0.11%
Previous 0.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$95.27 - $108.47 $389,749 - $443,750
4,091 Added 205.68%
6,080 $588,000
Q4 2023

Feb 07, 2024

BUY
$92.27 - $101.54 $183,525 - $201,963
1,989 New
1,989 $200,000
Q4 2022

Feb 15, 2023

SELL
$75.55 - $92.52 $26,744 - $32,752
-354 Reduced 8.01%
4,065 $368,000
Q3 2022

Nov 14, 2022

BUY
$74.61 - $87.26 $82,518 - $96,509
1,106 Added 33.38%
4,419 $336,000
Q2 2022

Aug 15, 2022

BUY
$80.52 - $93.75 $266,762 - $310,593
3,313 New
3,313 $280,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $229B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Principal Street Partners, LLC Portfolio

Follow Principal Street Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Street Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Principal Street Partners, LLC with notifications on news.